Quintessence Biosciences has confirmed the selection of an EVade cancer treatment for preclinical testing and human clinical trials. The compound, known as QB139, has been effective in inhibiting tumor growth in four human organs....
The end of a once promising partnership with Pfizer has not dissuaded a Madison biotechnology company from pursuing ways to bring drugs to market faster and more cost effectively. Deltanoid Pharmaceuticals, which was spun out of the University of Wisconsin-Madison, is pursuing Phase II funding...
With MatriLab's Kathleen Kelleher on the griddle, future angel and venture capital customers received some welcome insight into how investors evaluate early-stage companies. Their advice and counsel came during the National SBIR-STTR Conference in Milwaukee. ...
Dr. Timothy Flaherty, former chairman of the American Medical Association and deputy surgeon general of the U.S. Air Force, has been appointed to the board of directors of Kyron Clinical Imaging, a brain imaging software producer based in Wauwatosa. Flaherty has Wisconsin ties, including a...
The Madison biotechnology industry has proven that Wisconsinites can get beyond their reluctance to seek federal funding, but now that aggressive posture must be demonstrated by the rest of the state. At the 2006 National SBIR-STTR Conference in Milwaukee, both Wisconsin and Midwestern businesses are...
For all the concern about the compliance costs of Sarbanes-Oxley, the law has led to more independent boards of directors. At the recent University of Wisconsin-Madison Director's Summit, directors of several prominent corporate boards offered their advice about heading off the kind of trouble that...
The Midwest had 11 universities in the top 50 institutions winning NIH funding during 2005, including 20th ranked Wisconsin, according to Yer Biotech Blues columnist Michael Rosen. That's pretty impressive considering that NIH funding has been increasingly hard to come by, and it's a key...
At the University of Wisconsin-Madison, it's hard to imagine life without Bayh-Dole, the landmark law that fueled technology transfer in university communities across the nation. Still, the law is under attack, even by some academicians, which has compelled former U.S. Senator Birch Bayh, who co-authored...
The Center for Advanced Technology and Innovation, in its first major drive for nationwide visibility, has accepted a contract to assess 255 patents from two major Delaware companies that could spur new products, companies, and intrastate collaboration. There is a strong possibility that CATI will...
Madison's Third Wave Technologies reported a smaller net loss during the third quarter of 2006 on higher revenues for its molecular diagnostics products. Third Wave's $5.2 million net loss was was an improvement over its net loss of $7.4 million for the same period of...